Academy of Pediatrics. Provisional Committee for Quality Improvement and Subcommittee on Hyperbilirubinemia. Pediatrics 1994;94:558-65.
Bowman J. The management of hemolytic disease in the fetus and newborn. Semin Perinatol 1997;21:39-44.
Halperin DS, Wacker P, LaCourt G, et al. Effects of recombinant human erythropoi-etin in infants with the anemia of prematurity: a pilot study. J Pediatr 1990;116:779-96.
Hann IM, Gibson BES, Letsky EA. Fetal and Neonatal Haematology. London: Bailliere Tindall, 1991.
Maier RH, Obladen M, Müller-Hansen I, et al. Early treatment with erythropoietin [beta] ameliorates anemia and reduces transfusion requirements in infants with birth weights below 1000 g. J Pediatr 2002;141:8-15.
Messer J, Haddad J, Donato L, Astruc D, et al. Early treatment of premature infants with recombinant human erythropoietin. Pediatrics 1993;92:519-23.
Was this article helpful?